Adverse Prognostic Impact of Postoperative Complications After Gastrectomy for Patients With Stage II/III Gastric Cancer: Analysis of Prospectively Collected Real-World Data
Tóm tắt
The impact of postoperative complications on the prognosis of gastric cancer remains controversial. This study aimed to evaluate the relationship between postoperative complications and long-term survival in patients undergoing gastrectomy for stage II/III gastric cancer.
Some 939 patients underwent curative gastrectomy for stage II/III gastric cancer were identified from real-world data prospectively collected between 2013 and 2015. We divided patients according to the presence of serious complications, specifically, Clavien-Dindo grade III or higher complications or those causing a hospital stay of 15 days or longer.
Serious complications occurred in 125 (13.3%) patients. Patients without serious complications (64.3%) completed adjuvant chemotherapy significantly more than patients with serious complications (37.6%; p<0.001). The 5-year overall survival(OS) rate was 58.1% and recurrence-free survival(RFS) rate was 58.1% in patients with serious complications, which were significantly worse than those of patients without serious complications (73.4% and 74.7%, respectively; p<0.001 for both). In stage II, once patients completed adjuvant chemotherapy adequately, the OS and RFS of patients with serious complications did not differ from those without serious complications. However, in stage III, the patients with serious complications showed a worse OS even after completion of adequate adjuvant chemotherapy.
Serious complications after gastrectomy had a negative impact on the prognosis of stage II/III gastric cancer patients. Serious complications worsen the survival in association with inadequate adjuvant chemotherapy. Efforts to reduce serious complications, as well as support adequate chemotherapy through proper management of serious complications, would improve the prognosis of stage II/III gastric cancer patients.
Từ khóa
Tài liệu tham khảo
Bray, 2018, Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492
Brar, 2013, Defining Surgical Quality in Gastric Cancer: A RAND/UCLA Appropriateness Study, J Am Coll Surg, 217, 347, 10.1016/j.jamcollsurg.2013.01.067
Songun, 2010, Surgical Treatment of Gastric Cancer: 15-Year Follow-Up Results of the Randomised Nationwide Dutch D1D2 Trial, Lancet Oncol, 11, 10.1016/s1470-2045(10)70070-x
Kubota, 2014, Prognostic Significance of Complications After Curative Surgery for Gastric Cancer, Ann Surg Oncol, 21, 10.1245/s10434-013-3384-9
Lee, 2014, Risk Factors Associated With Complication Following Gastrectomy for Gastric Cancer: Retrospective Analysis of Prospectively Collected Data Based on the Clavien-Dindo System, J Gastrointest Surg, 18, 10.1007/s11605-014-2525-1
Lee, 2012, Comparison of Complications After Laparoscopy-Assisted Distal Gastrectomy and Open Distal Gastrectomy for Gastric Cancer Using the Clavien–Dindo Classification, Surg Endoscopy, 26, 10.1007/s00464-011-2027-0
Mrak, 2013, Impact of Postoperative Complications on Long-Term Survival After Resection for Rectal Cancer, Dis Colon Rectum, 56, 10.1097/DCR.0b013e31826f2672
Derks, 2005, Elderly Patients With Head and Neck Cancer: The Influence of Comorbidity on Choice of Therapy, Complication Rate, and Survival, Curr Opin Otolaryngol Head Neck Surg, 13, 10.1097/01.moo.0000156169.63204.39
Saeki, 2017, Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma, Ann Surg, 265, 10.1097/sla.0000000000001692
Tokunaga, 2013, Poor Survival Rate in Patients With Postoperative Intra-Abdominal Infectious Complications Following Curative Gastrectomy for Gastric Cancer, Ann Surg Oncol, 20, 10.1245/s10434-012-2720-9
Wang, 2019, Postoperative Complications and Prognosis After Radical Gastrectomy for Gastric Cancer: A Systematic Review and Meta-Analysis of Observational Studies, World J Surg Oncol, 17, 52, 10.1186/s12957-019-1593-9
Jung, 2012, Definition and Classification of Complications of Gastrectomy for Gastric Cancer Based on the Accordion Severity Grading System, World J Surg, 36, 10.1007/s00268-012-1693-y
Yang, 2016, Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction by Intracorporeal Anastomosis With Linear Staplers, J Am Coll Surg, 222, 10.1016/j.jamcollsurg.2016.01.002
Edge, 2010, AJCC cancer staging manual
Sakuramoto, 2007, Adjuvant Chemotherapy for Gastric Cancer With S-1, an Oral Fluoropyrimidine, N Engl J Med, 357, 10.1056/NEJMoa072252
Noh, 2014, Adjuvant Capecitabine Plus Oxaliplatin for Gastric Cancer After D2 Gastrectomy (CLASSIC): 5-Year Follow-Up of an Open-Label, Randomised Phase 3 Trial, Lancet Oncol, 15, 10.1016/s1470-2045(14)70473-5
Park, 2015, Proper Timing of Adjuvant Chemotherapy Affects Survival in Patients With Stage 2 and 3 Gastric Cancer, Ann Surg Oncol, 22, 10.1245/s10434-014-3949-2
Li, 2020, Impact of Postoperative Complications and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer, J Am Coll Surg, 230, 10.1016/j.jamcollsurg.2019.12.038
Jin, 2016, Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative, Ann Surg Oncol, 23, 10.1245/s10434-016-5121-7
Vicente, 2018, Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients With Complications After Gastrectomy, Ann Surg Oncol, 25, 10.1245/s10434-018-6638-8
An, 2012, Surgical Complications in Gastric Cancer Patients Preoperatively Treated With Chemotherapy: Their Risk Factors and Clinical Relevance, Ann Surg Oncol, 19, 10.1245/s10434-012-2267-9
Kwon, 2015, Risk Factors for Complications During Surgical Treatment of Remnant Gastric Cancer, Gastric Cancer, 18, 10.1007/s10120-014-0369-8
McMillan, 2009, Systemic Inflammation, Nutritional Status and Survival in Patients With Cancer, Curr Opin Clin Nutr Metab Care, 12, 10.1097/MCO.0b013e32832a7902